Totarol inhibits bacterial cytokinesis by perturbing the assembly dynamics of FtsZ

Biochemistry

Volumn 46, Issue 14, 2007, Pages 4211-4220

  Jaiswal, Richa ^a   Beuria, Tushar K ^a   Mohan, Renu ^a   Mahajan, Suresh K ^b   Panda, Dulal ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^b INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLUS SUBTILIS CELLS; BACTERIAL CYTOKINESIS; MYCOBACTERIUM TUBERCULOSIS; TOTAROL;

BACTERIA; CELL MEMBRANES; ENZYME INHIBITION; FLUORESCENCE; MICROMETERS; SELF ASSEMBLY;

PHENOLS;

8 ANILINO 1 NAPHTHALENESULFONIC ACID; FTSZ PROTEIN; GUANOSINE TRIPHOSPHATASE; MALEIMIDE DERIVATIVE; N (1 PYRENYL)MALEIMIDE; PHENOL; TOTAROL; UNCLASSIFIED DRUG;

ARTICLE; BACILLUS SUBTILIS; BACTERIAL CELL; CELL PROLIFERATION; CHROMOSOME STRUCTURE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOKINESIS; DISSOCIATION CONSTANT; ENZYME ACTIVITY; ENZYME INHIBITION; HELA CELL; HUMAN; HUMAN CELL; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY;

ANILINO NAPHTHALENESULFONATES; BACILLUS SUBTILIS; BACTERIAL PROTEINS; CELL PROLIFERATION; CYTOKINESIS; CYTOSKELETAL PROTEINS; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENCE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUORESCENT DYES; GTP PHOSPHOHYDROLASES; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOHISTOCHEMISTRY; INDOLES; MALEIMIDES; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT PROTEINS; RHODAMINES;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS; POSIBACTERIA;

EID: 34147136107     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi602573e     Document Type: Article

References (43)

1. Bhalla, K. N. (2003) Microtubule-targeted anticancer agents and apoptosis, Oncogene 22, 9075-9086.
2. Nagle, A., Hur, W., and Gray, N. S. (2006) Antimitotic agents of natural origin, Curr. Drug Targets 7, 305-326.
3. Panda, D., Rathinasamy, K., Santra, M. K., and Wilson, L. (2005) Kinetic suppression of microtubule dynamic instability by griseofulvin: implications for its possible use in the treatment of cancer, Proc. Natl. Acad. Sci. U.S.A. 102, 9878-9883.
4. Wilson, L., and Jordan, M. A. (2004) New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies, J. Chemother. 16, 83-85.
5. Addinall, S. G., and Holland, B. (2002) The tubulin ancestor, FtsZ, draughtsman, designer and driving force for bacterial cytokinesis, J. Mol. Biol. 318, 219-236.
6. Lowe, J., van den Ent, F., and Amos, L. A. (2004) Molecules of the bacterial cytoskeleton, Annu. Rev. Biophys. Biomol. Struct. 33, 177-198.
7. Michie, K. A., and Lowe, J. (2006) Dynamic filaments of the bacterial cytoskeleton, Annu. Rev. Biochem. 75, 467-492.
8. Margolin, W. (2005) FtsZ and the division of prokaryotic cells and organelles, Nat. Rev. Mol. Cell Biol. 6, 862-871.
9. Stricker, J., Maddox, P., Salmon, E. D., and Erickson, H. P. (2002) Rapid assembly dynamics of the Escherichia coli FtsZ-ring demonstrated by fluorescence recovery after photobleaching, Proc. Natl. Acad. Sci. U.S.A. 99, 3171-3175.
10. Errington, J., Daniel, R. A., and Scheffers, D. J. (2003) Cytokinesis in bacteria, Microbiol. Mol. Biol. Rev. 67, 52-65.
11. Corton, J. C., Ward, J. E., Jr., and Lutkenhaus, J. (1987) Analysis of cell division gene ftsZ (sulB) from Gram-negative and Gram-positive bacteria, J. Bacteriol. 169, 1 -7.
12. Desai, A., and Mitchison, T. J. (1998) Tubulin and FtsZ structures: functional and therapeutic implications, BioEssays 20, 523-527.
13. Projan, S. J. (2002) New (and not so new) antibacterial targets - from where and when will the novel drugs come?, Curr. Opin. Pharmacol. 2, 513-522.
14. Beuria, T. K., Santra, M. K., and Panda, D. (2005) Sanguinarine blocks cytokinesis in bacteria by inhibiting FtsZ assembly and bundling, Biochemistry 44, 16584-16593.
15. Margalit, D. N., Romberg, L., Mets, R. B., Hebert, A. M., Mitchison, T. J., Kirschner, M. W., and RayChaudhuri, D. (2004) Targeting cell division: small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality, Proc. Natl. Acad. Sci. U.S.A. 101, 11821-11826.
16. Wang, J., Galgoci, A., Kodali, S., Herath, K. B., Jayasuriya, H., Dorso, K., Vicente, F., Gonzalez, A., Cully, D., Bramhill, D., and Singh, S. (2003) Discovery of a small molecule that inhibits cell division by blocking FtsZ, a novel therapeutic target of antibiotics, J. Biol. Chem. 278, 44424-44428.
17. White, E. L., Suling, W. J., Ross, L. J., Seitz, L. E., and Reynolds, R. C. (2002) 2-Alkoxycarbonyl aminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ, J. Antimicrob. Chemother. 50, 111-114.
18. Bendall, J. G., and Cambie, R. C. (1995) Totarol: a non-conventional diterpenoid, Aust. J. Chem. 48, 883-917.
19. Kubo, I., Muroi, H., and Himejima, M. (1992) Antibacterial activity of totarol and its potentiation, J. Nat. Prod. 55, 1436-1440.
20. Constantine, G. H., Karchesy, J. J., Franzblau, S. G., and LaFleur, L. E. (2001) (+)-Totarol from Chamaecyparis nootkatensis and activity against Mycobacterium tuberculosis, Fitoterapia 72, 572-574.
21. Kubo, I., Muroi, H., and Kubo, A. (1994) Naturally occurring anti-acne agents, J. Nat. Prod. 57, 9-17.
22. Haraguchi, H., Oike, S., Muroi, H., and Kubo, I. (1996) Mode of antibacterial action of totarol, a diterpene from Podocarpus nagi, Planta Med. 62, 122-125.
23. Shapiro, S., and Guggenheim, B. (1998) Inhibition of oral bacteria by phenolic compounds. Part 1. QSAR analysis using molecular connectivity, Quant. Struct.-Act. Relat. 17, 327-337.
24. Micol, V., Mateo, C. R., Shapiro, S., Aranda, F. J., and Villalain, J. (2001) Effects of (+)-totarol, a diterpenoid antibacterial agent, on phospholipids model membranes, Biochim. Biophys. Acta 1511, 281-290.
25. Evans, G. B., Furneaux, R. H., Gainsford, G. J., and Murphy, M. P. (2000) The synthesis and anti bacterial activity of totarol derivatives. Part 3: Modification of ring-B, Bioorg. Med. Chem. 8, 1663-1675.
26. White, E. L., Ross, L. J., Reynolds, R. C., Seitz, L. E., Moore, G. D., and Borhani, D. W. (2000) Slow polymerization of Mycobacterium tuberculosis FtsZ, J. Bacteriol. 182, 4028-4034.
27. Santra, M. K., Beuria, T. K., Banerjee, A., and Panda, D. (2004) Ruthenium red-induced bundling of bacterial cell division protein, FtsZ, J. Biol. Chem. 279, 25959-25965.
28. Beuria, T. K., Krishnakumar, S. S., Sahar, S., Singh, N., Gupta, K., Meshram, M., and Panda, D. (2003) Glutamate-induced assembly of bacterial cell division protein FtsZ, J. Biol. Chem. 278, 3735-3741.
29. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248-254.
30. Geladopoulos, T. P., Sotiroudis, T. G., and Evangelopoulos, A. E. (1991) A malachite green colorimetric assay for protein phosphatase activity, Anal. Biochem. 192, 112-116.
31. Mukherjee, A., Santra, M. K., Beuria, T. K., and Panda, D. (2005) A natural osmolyte trimethylamine N-oxide promotes assembly and bundling of the bacterial cell division protein, FtsZ and counteracts the denaturing effects of urea, FEBS J. 272, 2760-2772.
32. Lee, J. C., Harrison, D., and Timasheff, S. N. (1975) Interaction of vinblastine with calf brain microtubule protein, J. Biol. Chem. 250, 9276-9282.
33. Gupta, K., Bishop, J., Peck, A., Brown, J., Wilson, L., and Panda, D. (2004) Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin, Biochemistry 43, 6645-6655.
34. Gupta, K., and Panda, D. (2002) Perturbation of microtubule polymerization by quercetin through tubulin binding: a novel mechanism of its antiproliferative activity, Biochemistry 41, 13029-13038.
35. Mohan, R., Banerjee, M., Ray, A., Manna, T., Wilson, L., Owa, T., Bhattacharyya, B., and Panda, D. (2006) Antimitotic sulfonamides inhibit microtubule assembly dynamics and cancer cell proliferation, Biochemistry 45, 5440-5449.
36. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesh, H., Kenney, S., and Boyd, M. R. (1990) New colorimetric cytotoxicity assay for anticancer drug screening, J. Natl. Cancer Inst. 82, 1107-1112.
37. Mukherjee, A., and Lutkenhaus, J. (1994) Guanine nucleotide-dependent assembly of FtsZ into filaments, J. Bacteriol. 176, 2754-2758.
38. Mingorance, J., Rueda, S., Gomez-Puertasm, P., Valencia, A., and Vicente, M. (2001) Escherichia coli FtsZ polymers contain mostly GTP and have a high nucleotide turnover, Mol. Microbiol. 41, 83-91.
39. Yu, X. C., and Margolin, W. (1998) Inhibition of assembly of bacterial cell division protein FtsZ by the hydrophobic dye 5,5′-bis-(8-anilino-1- naphthalenesulfonate), J. Biol. Chem. 273, 10216-10222.
40. Gunderson, S. M., Hayes, R. A., Quinn, J. P., and Danziger, L. H. (2004) In vitro pharmacodynamic activities of ABT-492, a novel quinolone, compared to those of levofloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis, Antimicrob. Agents Chemother. 48, 203-208.
41. Turner, J., Cho, Y., Dinh, N. N., Waring, A. J., and Lehrer, R. I. (1998) Activities of LL-37 a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42, 2206-2214.
42. Urgaonkar, S., La Pierre, H. S., Meir, I., Lund, H., RayChaudhuri, D., and Shaw, J. T. (2005) Synthesis of antimicrobial natural products targeting FtsZ: (±)-dichamanetin and (±)-2‴-hydroxy-5″- benzylisouvarinol-B, Org. Lett. 7, 5609-5612.
43. Ito, H., Ura, A., Oyamada, Y., Tanitame, A., Yoshida, H., Yamada, S., and Wachi, assembly of bacterial cell division protein FtsZ in vitro and in vivo, Microbiol. Immunol. 50, 759-764.